Literature DB >> 12514361

Dyshormonogenic hypothyroidism with normal neurological development, unexplained short stature and facial anomalies in three siblings.

Rahim Vakili1, Shahriar Jalali Mazlouman.   

Abstract

We report three members of a family with clinical and laboratory features, consistent with dyshormonogenic hypothyroidism, with an autosomal recessive pattern of inheritance. Two had primary hypothyroidism with normal Tc(99m) thyroid scans, presenting with growth delay at ages of 7.5 and 2, and one had hypoplasia of the right lobe of the thyroid with left lobe hemiagenesis and low thyroid uptake in iodide thyroid scan, diagnosed at 14 months. They had slender facies with nasal retrognathic mandible and a prominent bridge. They had reasonably normal intellectual development despite delayed onset of treatment. Despite advancement of bone age with treatment the patients remained significantly short. Possible differential diagnoses are dyshormonogenic hypothyroidism, especially hyporesponsiveness to thyrotropin and short stature that may be due to an abnormal gene in this family.

Entities:  

Mesh:

Year:  2003        PMID: 12514361     DOI: 10.1097/00019605-200301000-00004

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  3 in total

1.  Thyroid hemiagenesis and incidentally discovered papillary thyroid cancer: case report and review of the literature.

Authors:  A M Pizzini; G Papi; S Corrado; C Carani; E Roti
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  Thyroid Hemiagenesis: Narrative Review and Clinical Implications.

Authors:  Omotara Kafayat Lesi; Ankur Thapar; Nikhil Nanjappa Ballanamada Appaiah; Muhammad Rafaih Iqbal; Shashi Kumar; Dale Maharaj; Abdalla Saad Abdalla Al-Zawi; Shiva Dindyal
Journal:  Cureus       Date:  2022-02-20

3.  Does TSH Trigger the Anti-thyroid Autoimmune Processes? Observation on a Large Cohort of Naive Patients with Thyroid Hemiagenesis.

Authors:  Ewelina Szczepanek-Parulska; Ariadna Zybek-Kocik; Kosma Woliński; Barbara Czarnocka; Marek Ruchała
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-03-14       Impact factor: 4.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.